Insmed Incorporated (INSM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Insmed Incorporated, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -29.12x | -12.39x | -5.81x | -5.11x | -7.03x | -11.05x |
| P/B Ratio | 50.31x | 39.69x | -13.11x | 27.95x | 7.44x | 11.78x |
| P/S Ratio | 61.31x | 31.14x | 14.26x | 10.02x | 16.20x | 19.76x |
| Profitability | ||||||
| Gross Margin | 79.4% | 76.4% | 78.5% | 77.5% | 76.6% | 75.7% |
| Operating Margin | -194.0% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% |
| EBITDA Margin | -193.2% | -225.1% | -216.3% | -182.3% | -203.6% | -152.3% |
| Liquidity | ||||||
| Current Ratio | 3.83x | 5.45x | 4.12x | 6.69x | 6.19x | 5.24x |
| Quick Ratio | 3.54x | 5.12x | 3.75x | 6.33x | 5.70x | 4.83x |
| Leverage | ||||||
| Debt/Equity | 1.04x | 4.60x | -3.63x | 13.39x | 1.49x | 1.47x |
YoY = year-over-year change. Source: FMP..